(Q28731816)

English

FGFR2 point mutations in 466 endometrioid endometrial tumors: relationship with MSI, KRAS, PIK3CA, CTNNB1 mutations and clinicopathological features

scientific article (publication date: 2012)

In more languages

Statements

scholarly article

0 references

FGFR2 point mutations in 466 endometrioid endometrial tumors: relationship with MSI, KRAS, PIK3CA, CTNNB1 mutations and clinicopathological features (English)

0 references

object named as

Sara A Byron

1

0 references

Pamela M. Pollock

object named as

Pamela M Pollock

8

0 references

object named as

Feng Gao

5

0 references

author name string

Michael Gartside

2

0 references

Matthew A Powell

3

0 references

Candice L Wellens

4

0 references

David G Mutch

6

0 references

Paul J Goodfellow

7

0 references

language of work or name

0 references

publication date

2012

0 references

0 references

7

0 references

e30801

0 references

2

0 references

copyright license

Creative Commons Attribution 4.0 International

23 February 2012

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

Cancer statistics, 2010

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3285611

17 March 2017

Inhibition of activated fibroblast growth factor receptor 2 in endometrial cancer cells induces cell death despite PTEN abrogation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3285611

17 March 2017

Mutations in fibroblast growth factor receptor 2 and fibroblast growth factor receptor 3 genes associated with human gastric and colorectal cancers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3285611

17 March 2017

A simple salting out procedure for extracting DNA from human nucleated cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3285611

17 March 2017

High frequency of PIK3R1 and PIK3R2 mutations in endometrial cancer elucidates a novel mechanism for regulation of PTEN protein stability

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3285611

3 June 2018

Targeting mutant fibroblast growth factor receptors in cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3285611

3 June 2018

A unique spectrum of somatic PIK3CA (p110alpha) mutations within primary endometrial carcinomas

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3285611

3 June 2018

Integrative molecular profiling of triple negative breast cancers identifies amplicon drivers and potential therapeutic targets

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3285611

3 June 2018

Biologic markers in endometrial cancer treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3285611

3 June 2018

Mitogen-activated protein kinases and Wnt/beta-catenin signaling: Molecular conversations among signaling pathways

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3285611

3 June 2018

Drug-sensitive FGFR2 mutations in endometrial carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3285611

3 June 2018

Frequent activating FGFR2 mutations in endometrial carcinomas parallel germline mutations associated with craniosynostosis and skeletal dysplasia syndromes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3285611

3 June 2018

Somatic mutations of the protein kinase gene family in human lung cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3285611

3 June 2018

Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3285611

3 June 2018

The transmembrane mutation G380R in fibroblast growth factor receptor 3 uncouples ligand-mediated receptor activation from down-regulation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3285611

3 June 2018

Fibroblast growth factor receptor 3 (FGFR3) transmembrane mutation in Crouzon syndrome with acanthosis nigricans

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3285611

3 June 2018

A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3285611

3 June 2018

CGH, cDNA and tissue microarray analyses implicate FGFR2 amplification in a small subset of breast tumors.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3285611

20 June 2018

Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0030801

21 January 2018

Up-regulation and co-expression of fibroblast growth factor receptors in human gastric cancer

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0030801

21 January 2018

Novel fibroblast growth factor receptor 3 (FGFR3) mutations in bladder cancer previously identified in non-lethal skeletal disorders

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0030801

21 January 2018

Pathogenic activation of receptor tyrosine kinases in mammalian membranes

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0030801

21 January 2018

Mutual exclusiveness between PIK3CA and KRAS mutations in endometrial carcinoma.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0030801

21 January 2018

Ten-year results of a prospective study on the prognostic role of ploidy in endometrial carcinoma: dNA aneuploidy identifies high-risk cases among the so-called 'low-risk' patients with well and moderately differentiated tumors

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0030801

21 January 2018

PIK3CA mutations and amplification in endometrioid endometrial carcinomas: relation to other genetic defects and clinicopathologic status of the tumors.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3285611

27 November 2018

Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC Trial): a randomized study

1 reference

https://pubmed.ncbi.nlm.nih.gov/22383975

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Retrospective Analysis of Selective Lymphadenectomy in Apparent Early-Stage Endometrial Cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/22383975

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Microsatellite Instability and Epigenetic Inactivation ofMLH1and Outcome of Patients With Endometrial Carcinomas of the Endometrioid Type

1 reference

https://pubmed.ncbi.nlm.nih.gov/22383975

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Differences in patterns of TP53 and KRAS2 mutations in a large series of endometrial carcinomas with or without microsatellite instability

1 reference

https://pubmed.ncbi.nlm.nih.gov/22383975

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study

1 reference

https://pubmed.ncbi.nlm.nih.gov/22383975

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

PIK3CA mutations in the kinase domain (exon 20) of uterine endometrial adenocarcinomas are associated with adverse prognostic parameters

1 reference

https://pubmed.ncbi.nlm.nih.gov/22383975

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pelvic lymph node count is an important prognostic variable for FIGO stage I and II endometrial carcinoma with high-risk histology

1 reference

https://pubmed.ncbi.nlm.nih.gov/22383975

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1371/JOURNAL.PONE.0030801

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

2012PLoSO...730801B

0 references

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28731816&oldid=1868165332"